Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cholera Conjugate Vaccine - International Vaccine Institute

Next Previous
Drug Profile

Cholera Conjugate Vaccine - International Vaccine Institute

Alternative Names: O Specific Polysaccharide recombinant Tetanus Toxoid Heavy Chain Fragment cholera conjugate vaccine; OSP:rTTHc Cholera Conjugate Vaccine

Latest Information Update: 31 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator International Vaccine Institute
  • Developer EuBiologics; International Vaccine Institute
  • Class Cholera vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Cholera

Most Recent Events

  • 23 Jan 2024 EuBiologics in collaboration with International Vaccine Institute completes a phase I trial in Cholera (Prevention) in South Korea (IM, injection) (NCT05559983)
  • 30 Nov 2022 Phase-I clinical trials in Cholera (Prevention, In adults) in South Korea (IM) (NCT05559983)
  • 04 Oct 2022 Preclinical trials in Cholera (Prevention) in South Korea (IM), prior to September 2022 (NCT05559983)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top